| 摘要 |
The present application discloses an immunogenic composition comprising a Hib saccharide conjugate, at least one additional bacterial, for example N. meningitidis, saccharide conjugate(s), and a further antigen selected from the group consisting of whole cell pertussis and hepatitis B surface antigen, wherein the saccharide dose of the Hib saccharide conjugate is less than 5µg. |
| 申请人 |
GLAXOSMITHKLINE BIOLOGICALS S.A.;BIEMANS, RALPH, LEON;BOUTRIAU, DOMINIQUE;CAPIAU, CARINE;DENOEL, PHILIPPE;DUVIVIER, PIERRE;POOLMAN, JAN |
发明人 |
BIEMANS, RALPH, LEON;BOUTRIAU, DOMINIQUE;CAPIAU, CARINE;DENOEL, PHILIPPE;DUVIVIER, PIERRE;POOLMAN, JAN |
